Filter
2405
Filtered Results: 2405
Text search:
drug
trial
Featured
Recommendations
228
New Publications
471
Language
Document type
No document type
1438
Guidelines
376
Studies & Reports
361
Manuals
95
Strategic & Response Plan
45
Fact sheets
40
Training Material
20
Situation Updates
12
Infographics
8
Resource Platforms
6
Brochures
3
App
1
Countries / Regions
India
135
Global
79
South Africa
61
Western and Central Europe
55
Kenya
40
Ethiopia
37
Africa
37
Uganda
34
Nigeria
33
Eastern Europe
29
Liberia
27
Zambia
27
Tanzania
26
Russia
26
Ukraine
25
Sierra Leone
24
Nepal
24
Malawi
23
Zimbabwe
20
Ghana
19
Rwanda
19
Latin America and the Carribbean
19
Philippines
16
Bangladesh
15
Brazil
14
South–East Asia Region
14
East and Southern Africa
13
Myanmar / Burma
12
Asia
12
Mozambique
11
Namibia
11
Colombia
11
West and Central Africa
11
Germany
10
Cambodia
10
Lesotho
10
USA
9
South Sudan
9
Indonesia
9
Middle East and North Africa
9
Congo, Democratic Republic of
7
Eswatini/ Swaziland
7
Botswana
7
Syria
6
Thailand
6
Cameroon
5
Eastern Europe and Central Asia
5
Albania
5
Tajikistan
5
Guinea
4
Burkina Faso
4
Senegal
4
Sudan
4
Argentina
4
Georgia
4
Vietnam
4
Pakistan
3
Lebanon
3
Central African Republic
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Spain
3
Guinea-Bissau
2
Morocco
2
Haiti
2
Iraq
2
Jordan
2
China
2
Papua New Guinea
2
Benin
2
North Macedonia
2
Hungary
2
Bolivia
2
Mexico
2
Sri Lanka
2
Poland
2
Southern Africa
2
Estonia
2
Iran
2
Kyrgyzstan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Turkey
1
Gambia
1
Ireland
1
Singapore
1
Peru
1
Ecuador
1
Greece
1
Madagascar
1
Bhutan
1
Armenia
1
Qatar
1
Bulgaria
1
Lithuania
1
Kazakhstan
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
638
Clinical Guidelines
334
Public Health
137
Women & Child Health
96
Pharmacy & Technologies
29
Key Resources
24
Capacity Building
19
Toolboxes
HIV
336
Mental Health
331
TB
294
COVID-19
158
NTDs
110
AMR
85
NCDs
76
Pharmacy
65
Ebola
56
Rapid Response
34
Caregiver
27
Refugee
26
Disability
24
Planetary Health
22
Global Health Education
16
Conflict
14
Health Financing Toolbox
11
Polio
8
Cholera
5
Natural Hazards
5
Specific Hazards
5
Social Ethics
5
Zika
3
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-... interaction panel and now consists of six main sections, including a general overview table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanese
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
Clinical management standard operating procedures.
Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
